Anthony Thomas

Brown Foundation

Papers

1

Total Citations

48

H-Index

1

About

Anthony Thomas is a leading researcher in cardiovascular and molecular pharmacology, with a primary focus on the nitric oxide (NO)/cGMP signaling pathway and its regulatory mechanisms. His most cited work, "α1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity" (2008, 48 citations), provides critical insights into the structural and functional diversity of soluble guanylyl cyclase (sGC)—a key enzyme mediating NO-dependent effects. Thomas demonstrated that the α1/β1 sGC heterodimer, the predominant isoform in human tissues, may be modulated by alternative splice forms, revealing novel layers of regulation in vascular and cellular signaling. This foundational research has implications for understanding diseases like hypertension and heart failure, where NO signaling is disrupted. While his citation count reflects a focused, high-impact contribution, Thomas’s work stands out for its mechanistic depth and potential therapeutic relevance. His findings have paved the way for further studies on sGC as a drug target, making him a respected figure in the field of signal transduction and vascular biology.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
α1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity
48 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Brown Foundation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago